{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0169-1912",
      "marketing_end_date": "20270831",
      "generic_name": "dasiglucagon",
      "labeler_name": "Novo Nordisk",
      "brand_name": "Zegalogue",
      "active_ingredients": [
        {
          "name": "DASIGLUCAGON",
          "strength": ".6 mg/.6mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0169-1912-01",
          "description": "1 CONTAINER in 1 PACKAGE (0169-1912-01)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230626",
          "marketing_end_date": "20270831",
          "sample": false
        },
        {
          "package_ndc": "0169-1912-02",
          "description": "2 PACKAGE in 1 CARTON (0169-1912-02)  / 1 CONTAINER in 1 PACKAGE (0169-1912-12)  / 1 SYRINGE, GLASS in 1 CONTAINER / .6 mL in 1 SYRINGE, GLASS",
          "marketing_start_date": "20230626",
          "marketing_end_date": "20270831",
          "sample": false
        }
      ],
      "openfda": {
        "manufacturer_name": [
          "Novo Nordisk"
        ],
        "rxcui": [
          "2535238",
          "2535243",
          "2535247",
          "2535249"
        ],
        "spl_set_id": [
          "14704879-872c-4967-8779-04a3bbdfb4e6"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000190852",
          "N0000193923",
          "N0000009345"
        ],
        "pharm_class_epc": [
          "Antihypoglycemic Agent [EPC]"
        ],
        "pharm_class_moa": [
          "Glucagon Receptor Agonists [MoA]"
        ],
        "pharm_class_pe": [
          "Increased Glycogenolysis [PE]"
        ],
        "unii": [
          "AD4J2O47FQ"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "INJECTION, SOLUTION",
      "spl_id": "df9fed8a-f13a-4ef4-90cc-8ba51909d30c",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "SUBCUTANEOUS"
      ],
      "marketing_start_date": "20230626",
      "product_id": "0169-1912_df9fed8a-f13a-4ef4-90cc-8ba51909d30c",
      "application_number": "NDA214231",
      "brand_name_base": "Zegalogue",
      "pharm_class": [
        "Antihypoglycemic Agent [EPC]",
        "Glucagon Receptor Agonists [MoA]",
        "Increased Glycogenolysis [PE]"
      ]
    }
  ]
}